UBS Group AG - PREDICTIVE ONCOLOGY INC ownership

PREDICTIVE ONCOLOGY INC's ticker is and the CUSIP is 74039M200. A total of 32 filers reported holding PREDICTIVE ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PREDICTIVE ONCOLOGY INC
ValueSharesWeighting
Q1 2023$7,822
+1284.4%
23,922
+1213.7%
0.00%
Q4 2022$565
-90.6%
1,821
-88.6%
0.00%
Q3 2022$6,00016,043
+2790.6%
0.00%
Q2 2022$0
-100.0%
555
-98.5%
0.00%
Q4 2021$35,000
+40.0%
36,666
+95.2%
0.00%
Q3 2021$25,000
+400.0%
18,788
+411.2%
0.00%
Q2 2021$5,000
-81.5%
3,675
-90.2%
0.00%
Q4 2020$27,000
+1250.0%
37,386
+1274.0%
0.00%
Q3 2020$2,000
-71.4%
2,721
-34.6%
0.00%
Q2 2020$7,000
-22.2%
4,161
-30.5%
0.00%
Q1 2020$9,000
+80.0%
5,990
+196.4%
0.00%
Q4 2019$5,0002,0210.00%
Other shareholders
PREDICTIVE ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Fusion Capital, LLC 12,000$16,0000.01%
Csenge Advisory Group 22,500$29,0000.00%
TWO SIGMA SECURITIES, LLC 48,166$63,0000.00%
Private Advisor Group, LLC 26,805$35,0000.00%
NewSquare Capital LLC 2,500$3,0000.00%
VICTORY CAPITAL MANAGEMENT INC 10,091$13,0000.00%
Focused Wealth Management, Inc 200$00.00%
UBS Group AG 3,675$5,0000.00%
Squarepoint Ops LLC 25,348$33,0000.00%
OSAIC HOLDINGS, INC. 6,920$10,0000.00%
View complete list of PREDICTIVE ONCOLOGY INC shareholders